Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamics

Area of Science:

• Molecular biology
• Pharmacology
• Biochemistry

Background:

• Exchange proteins activated by cAMP (EPAC) are crucial in physiological processes.
• EPAC1 inhibition shows therapeutic potential in cardiac diseases.
• AM-001 is a selective EPAC1 antagonist with a non-competitive mechanism.

Purpose of the Study:

• To identify the allosteric binding site of AM-001 on EPAC1.
• To understand the molecular interactions of AM-001 with EPAC1.
• To validate the binding site using AM-001 analogues.

Main Methods:

• Cosolvent molecular dynamics simulations to identify potential binding sites.
• Molecular docking and dynamics simulations to determine AM-001 binding.
• Principal component analysis to characterize protein motion.

Main Results:

• A suitable allosteric binding pocket for AM-001 on EPAC1 was identified.
• Binding poses of AM-001 analogues correlated with their biological potency.
• Allosteric inhibitor binding induced an inactive-like conformation of EPAC1.

Conclusions:

• The study successfully localized the allosteric site of AM-001 on EPAC1.
• This finding provides a structural basis for designing novel EPAC1-targeted therapeutics.
• Understanding allosteric modulation of EPAC1 is key for developing new treatments.